Observational analysis reveals that intelectin-1 may modulate asthma through the gut-bone-lung axis, suggesting a link to immune regulation.
ITLN1 is a promising therapeutic target linking gut microbial metabolism to asthma immune regulation using the gut‒bone‒lung axis.
No takes yet. Share an insight, caveat, or question.
HE et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: